Anna and Peter originally hoped to find a vacation home that was big enough to share with friends and family and looked at the inn more out of curiosity than with any real intention to purchase it. I would love for [the Blue Horse Inn] to be the kind of place that a writer just starting on a novel escapes to for hospitality and inspiration, Keri said, adding that she hopes the new business still allows her some time for her own writing. Shes currently earning her PhD in European History at Boston College. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. Refer a Friend and Earn One Month of Free Membership. The Entrepreneur's Guide to a Biotech Startup. More than 100 drug developers thinned their organization charts last year. Peter Kolchinsky: It has infected people in different parts of the world. No. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.92B . Sign up here. Things here have been busy; were working hard to get the inn ready for our June 2010 grand opening. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Endpoints News Top biotech investor Peter Kolchinsky tees up a new SPAC 3 days after a $300M raise for radiopharmaceuticals play News Dec 9, 2020 Endpoints News RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and other similar diseases He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. "Stay tuned for more covid and science explainers. Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. and bought an estimated value of $190.71M worth of shares. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Baeder explains below not only whats coming for AAM and its member generic drug companies, but also her thoughts on the Inflation Reduction Act and the new five-year FDA user fee deal. He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. . Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. This slide deck contains a powerful visual illustration of the biotech industry's race to find a cure for Hepatitis C. Run through the slide deck quickly to appreciate the sheer level of hustle that won the world a cure, and then more slowly to appreciate every move in the chess game of mergers & acquisitions. $5M . When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data https://t.co/y9IG2Z5txl" In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. Insider trading is most common in June, with the busiest year in 2022. May 5, 2003 Like all mothers, Evelina Kolchinsky wanted her son, Peter, to adjust to school and do well. as vibrant from the outside as it is on the inside. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. New to Endpoints? Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. He currently manages a fund that invests in healthcare and biotechnology companies. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. But many people worry that Covid-19 will mutate and . This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky is a biotechnology investor and a scientist. So lets meet our newest neighbors in Woodstock. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Verified account Protected Tweets @; Suggested users The higher rates are proposed to kick in on April 1. Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. In this conversation. I don't believe that temperature plays a role in the spread of Covid-19. Peter Kolchinsky, Ph.D., has more than 18 years of experience in healthcare investing and is the founder of and a managing partner at RA Capital. Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. The two announced Monday morning that theyve put together their first pure-play venture fund at RA Capital Management, which has been known to bet on just about every angle in healthcare investing from rounds to follow-on investments at public companies. var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. Ilan Ganot, Director, Let us know who we should consider our main ask is that you make the nominations personal. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. 2001 - Present22 years. If you're already an Endpoints subscriber, enter your email below for a Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Your email address will not be published. Let us know if you like it and we may post more pieces with this option.) Carl Ashley Morris who sold, In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. Refer a Friend and Earn One Month of Free Membership. The most active traders at the company are Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of $9.83M Stock quotes provided by InterActive Data. Peter Kolchinsky owns about 1,311,247 units of Mineralys. Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by With a few impressions we look back on this event and would like to thank very much all companies who made the North Keri is also a writer and is currently working on a Southern gothic novel. The drug industry stands accused of charging too much. Verified account Protected Tweets @ Protected Tweets @ Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. Add it to the rest of the money and their private deal capacity jumps to $1 billion, with $2.5 billion under management. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.89B . Anna and Keri hope their husbands dont electrocute themselves in the process. Everyone has been so generous with us, sharing advice and stories, and we hope that what we do with the inn will come to reflect the spirit of this wonderful community.. Arab Health 2023? Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation In . In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. Required fields are marked *. He currently manages a fund that invests in healthcare and biotechnology companies. and Catherine James, EVP and General Counsel Anthony Pompliano Net Worth Phone Number, House Address, Wiki, Ashley Massengill Net Worth | Bio, Family, Address, Career, Atlas Monroe Net Worth | Age, Height, Weight, Dating And More, Beyonce S Net Worth Phone Number, House Address, Wiki, Blue Ivy Net Worth Phone Number, House Address, Wiki. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.7B . Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. They will be in plain English and use colorful analogies." . hope that what we do with the inn will come to reflect the spirit of this wonderful community. Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. Ben, a storyteller and football aficionado, looks forward to evenings of camaraderie with locals and inn guests. They know that 3 Church Street is part of Woodstocks history and hope to create a place where not only guests but also the community will feel welcome. Peter Kolchinsky owns about 1,311,247 units of Mineralys Therapeutics, Inc common stock. magic link that lets you log in quickly without using a password. Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. the community will feel welcome. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. There are also venture partner and executive-in-residence programs to build up the bench. Bens got me beat so far by three perch and a bass and Im trying to catch up, 2010. (LogOut/ The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. Peter Kolchinsky overall profits are growing on a daily basis, and he is becoming more popular on the sidelines. Peter Kolchinsky: We need to see the difference between a true re-infection. But there was a lot of adjusting to do, for everyone in the family. Fundamental company data provided by Morningstar, updated daily. As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. Below is a lightly edited and condensed version of the interview. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! How do you see re-infections? Unlock this article along with other benefits by subscribing to one of our paid plans. Hard work has helped him rise to the top. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Industry is going to have to give "a pound of flesh," Kolchinsky argued, and he's explicit on the business practices biopharma must abandon to get a fair system that still rewards innovation. Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $38,029,167 and over the last 9 years he sold WVE stock worth over $58,095,632. Fundamental company data provided by Morningstar, updated daily. Wishing you all the best of luck in your new endeavor. Peter Kolchinsky usually trades in December, with the busiest year in 2022. On average, Wave Life Sciences executives and independent directors trade stock every 39 days with the average trade being worth of $949,631. Currently, Peter is married. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Blog at WordPress.com.RSS 2.0Comments RSS 2.0, The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. More Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Over the last 8 years, insiders at Wave Life Sciences have traded over $18,606,802 worth of Wave Life Sciences stock and bought 14,319,108 units worth $106,704,225 and Ian F Smith, Director . RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . These were worth $145 million and represented 2% of its portfolio. The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . The Kolchinskys came. In addition, they want, Coming from diverse backgrounds and interests, the foursome. Executives behind AI and precision medicine startup Tempus are putting together another AI outfit in Chicago focused on oncology drug discovery and development. So they invited their close friends Keri and Ben up for what they expected to be a reality check. Peter Kolchinsky owns about 10,916,567 units of Solid. The group has been building an incubator with 19 projects and two startups to their credit. Gurus may be added or dropped from the GuruFocus site at any time. Catalys Pacific Fund Lp, Novartis can't make enough of it, Q&A with Christine Baeder, new chair of the generic industrys AAM, UK government plans to hike revenue clawback rates beginning in April, Merz Aesthetics hands the mic to Christina Aguilera in Botox rival campaign. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main (LogOut/ Its certain to be a challenging one! May 27, 2022 (This is a long piece; click here to read it in Bionic Reading format, which may for some increase reading speed and comprehension. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. and Peter Kolchinsky, Director It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. 2004-2023 GuruFocus.com, LLC. In addition, they want to provide guests with ample opportunities to enjoy local arts, food, and activities and look forward to collaborating with local artists, craftsmen, and business owners to come up with interesting packages. $140.3K . You are looking for the virus through an RT-PCR test. Covid-19. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In addition to The Great American Drug Deal, he is the author of The Entrepreneurs Guide to a Biotech Startup. . 2004-2023 GuruFocus.com, LLC. Franklin Resources Inc, we figured our friends and family would try to talk us out of it, said Anna. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Gurus may be added or dropped from the GuruFocus site at any time. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. What an undertaking! Peter Kolchinsky - Insider Trading Tracker . Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. The most active traders at the company are He is active in both public and private investments in companies developing drugs, medical devices, diagnostics and research tools and serves as a board member for various public and privately-held . Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. All Rights Reserved. Well be posting shots of the different projects around the inn in the coming weeks, but first we thought you might like to know a little bit about us. Kolchinsky Peter Ownership Network Ownership Network List of Kolchinsky Peter Name Position Linked company No Data Ownership Network Relation of Kolchinsky Peter Kolchinsky Peter Mailing Address Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. $12.54M on September 23, 2020. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Carl Ashley Morris who sold 441 units worth The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. Robert Flexon, President and CEO, To their delight, Keri and Ben, long-time city dwellers, were immediately taken with the town and the inn, and they, too, embraced the vision of a life filled with New England hospitality, nature, and, adds Ben, equal parts fly fishing and snow shoveling. Internal digital and data science expertise is critical to developing a united value proposition that aligns the benefits of the digital and medicinal product. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . $12.69M on March 23, 2021. Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. Anna maintains relationships with many people -- family . See Peter Kolchinsky's compensation, career history, education, & memberships. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". This ground-breaking new book, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines (January 20, 2020), by Peter Kolchinsky, PhD, examines the healthcare landscape through the lens of the biotech social contract with America - the implicit agreement between the biopharmaceutical industry and American society - including the government's role in inventing . Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name Adam Levy, CFO, The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. , Keri said, adding that she hopes the new business still allows her some time for her own writing. Carl Ashley Morris, Chief Scientific Officer, Anna Kolchinsky was born on 03/30/1979 and is 43 years old. $20M on February 16, 2023. The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. Peter Kolchinsky's largest purchase order was 2,805,045 units , worth over Anna is excited about introducing her dressage horse Jurist to the local network of trails. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. Stock quotes provided by InterActive Data. Anna and Peter discovered Woodstock through Annas participation at the GMHA dressage events. Health Care. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. In support of his arguments, he shared insights from government and industry professionals and cited facts and figures on the trajectory of the drug market. The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Change), You are commenting using your Twitter account. The most active traders at the company are She has a Masters in theological studies from Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. The Statutory Scheme, which is governed under UK law, is one of two that companies can use. After serving in the US Air Force JAG Corps, Ben worked at a private law firm and in Massachusetts state government. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. Wallmine is a radically better financial terminal. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. . Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. So they invited their close friends Keri and Ben up for what they, Keri and Ben, long-time city dwellers, were, new dream and a substantial life-style change, One of my favorite paintings is from the Blue Horses, , and, of course, horses were what brought the couple to Woodstock. Lefkofsky co-founded Groupon, is a trustee of many marquee Chicago institutions and co-manages the Midwest VC firm Lightbank, which is currently looking to raise $250 million for its third fund, per another document filed with the SEC last November. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. This investment adviser does not provide advice to individual investors. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. . By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. Current Endpoints readerscan visit their reader profileto add Endpoints Weekly. On average, Rajeev trades about 455,121 units every 31 days since 2016. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. "And another thread that speaks to need for insurance reform. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. These things have helped him get to where he is now one of the richest people on Earth. worked in film production in Berlin for several years before returning to Boston, where she met Peter. Please note this link is one-time use only and is valid for only 24 hours. Peter Kolchinsky's largest purchase order was 3,178,476 units , worth over Past performance is a poor indicator of future performance. one-time use only and expires after 24 hours. Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion . Right now, he is the most trending person in social media. Words cant bring Christina Aguilera down but frown lines can. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback